Prevention of peritoneal carcinomatosis in mice by combining hyperthermal intraperitoneal chemotherapy with the water extract from burr parsley (Caucalis platycarpos L.)

Planta Medica

Volumn 76, Issue 8, 2010, Pages 773-779

  Oršolić, Nada ^a   Bevanda, Milenko ^b   Kujundi, Nikola ^c   Plazonic, Ana ^d   Stajcar, Damir ^e   Kujundi, Milan ^f  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Clinical Hospital Mostar   (Bosnia and Herzegovina)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d Agency for Medicinal Products and Medical Devices   (Croatia)

^e General Hospital   (Croatia)

^f University of Zagreb School of Medicine   (Croatia)

Author keywords

Apiaceae; Caucalis platycarpos L.; Chemotherapy; Hyperthermia; Mouse; Peritoneal carcinomatosis

Indexed keywords

ANTINEOPLASTIC AGENT; CAUCALIS PLATYCARPOS EXTRACT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN; MUTOMYCIN; PLATIMID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APIALES; ARTICLE; BURR PARSLEY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CARCINOMATOSIS; CAUCALIS PLATYCARPOS; CONTROLLED STUDY; COOLING; DRUG EFFICACY; DRUG POTENTIATION; DRUG TREATMENT FAILURE; FEMALE; HYPERTHERMIC THERAPY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PERITONEAL CARCINOMATOSIS; RECTUM TEMPERATURE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APIACEAE; COMBINED MODALITY THERAPY; FEMALE; HYPERTHERMIA, INDUCED; MALE; MICE; MICE, INBRED CBA; PERITONEAL NEOPLASMS; PLANT EXTRACTS; WATER;

ANIMALIA; APIACEAE; CAUCALIS; CAUCALIS PLATYCARPOS; MUS;

EID: 77952935890     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240723     Document Type: Article

References (45)

1. Hahn G M. Hyperthermia and cancer. New York Plenum Publishing Corp 1982
2. Meyn R E., Corry P M., Fletcher S E., Demetriades M. Thermal enhancement of DNA strand breakage in mammalian cells treated with bleomycin. Int J Radiat Oncol Biol Phys 1979 5 1487-1489
3. Kawai N, Ito A, Nakahara Y, Futakuchi M, Shirai T, Honda H, Kobayashi T, Kohri K. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 2005 64 373-381
4. Mohamed F, Marchettini P, Stuart O A., Urano M, Sugarbaker P H. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol 2003 10 463-468
5. Stewart J H., Shen P, Levine E A. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 2005 12 765-777
6. Verwaal V J., van Ruth S, de Bree E, van Sloothen G W., van Tinteren H, Boot H, Zoetmulder F A. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003 21 3737-3743
7. Ewens A, Luo L, Berleth E, Alderfer J, Wollman R, Hafeez B B., Kanter P, Mihich E, Ehrke M J. Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Res 2006 66 5419-5426
8. Kujundi M, Bai I, Kujundi N. Therapy of liver methastases of colorectal cancer by plant extract from Caucalis platycarpos L. Acta Pharm 1997 47 39-45
9. Radai M, Borani M, Bai I. A mouse mammary carcinoma as a model for evaluation of drug effect on primary tumor growth and metastases. Lapis K, Jenely Ai, Price M Tumor progression and markers. Amsterdam Kugler Publications 1983 217-223
10. Bai I, Varga E. Immunogenicity of mammary carcinoma and a fibrosarcoma of CBA mice. Period Biol 1979 81 335-337
11. Oroli N, Bai I. Immunomodulation by water-soluble derivative of propolis (WSDP) a factor of antitumor reactivity. J Ethnopharmacol 2003 84 265-273
12. Christ B, Mller K H. Zur serienmigen Bestimmung des Gehaltes an Flavonol-Derivaten in Drogen. Arch Pharm Ber Dtsch Pharmaz Ges 1960 293 1033-1042
13. European Pharmacopoeia 5.0, Vol. 1560. Strasbourg, France Council of Europe 2004 01 2005 2377-2378
14. Cuyckens F, Claeys M. Mass spectrometry in the structural analysis of flavonoids. J Mass Spectrom 2004 39 1-15
15. Es-Safi N E., Kerhoas L, Einhorn J, Ducrot P-H. Application of ESI/MS, CID/MS and tandem MS/MS to the fragmentation study of eriodictyol 7- O -glucosyl-(12)-glucoside and luteolin 7- O -glucosyl-(12)-glucoside. Int J Mass Spectrom 2005 247 93-100
16. Jin Y, Xiao Y, Zhang F, Xue X, Xu Q, Liang X. Systematic screening and characterization of flavonoid glycosides in Carthamus tinctorius L. by liquid chromatography/UV diode-array detection/electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 2008 46 418-430
17. Ma Y L., Li Q M., Van den Heuvel H M., Claeys M. Characterization of flavone and flavonol aglycones by collision-induced dissociation tandem mass spectrometry. Rapid communication. Mass Spectrom 1997 11 1357-1364
18. Simonovska B, Vovk I, Andrenek S, Valentov K, Ulrichova J. Investigation of phenolic acids in yacon (Smallanthus sonchifolius) leaves and tubers. J Chromatogr A 2003 1016 89-98
19. n identification of chlorogenic acids. J Agric Food Chem 2003 51 2900-2911
20. n. J Agric Food Chem 2005 53 3821-3832
21. Plowman J, Dykes D J., Hollingshead M. Anticancer drug development guide: preclinical screening, clinical trials, and approval. Totowa, NJ Humana 1995 101-107
22. Kaplan E L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53 457-465
23. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959 22 719-748
24. van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002 13 1173-1184
25. Halamikova A, Vrana O, Kasparkova J, Brabec V. Biochemical studies of the thermal effects on DNA modifications by the antitumor cisplatin and their repair. Chembiochem 2007 8 2008-2015
26. Roti J L. Heat-induced alterations of nuclear protein associations and their effects on DNA repair and replication. Int J Hyperthermia 2007 23 3-15
27. Takahashi A, Yamakawa N, Mori E, Ohnishi K, Yokota S, Sugo N, Aratani Y, Koyama H, Ohnishi T. Development of thermotolerance requires interaction between polymerase-beta and heat shock proteins. Cancer Sci 2008 99 973-978
28. Komarova L N., Petin V G., Saenko A S. The recovery parameters of DNA strand breaks of Ehrlich ascites cells after the combined action of ionizing radiation and hyperthermia. Radiats Biol Radioecol 2007 47 584-590
29. Radons J, Multhoff G. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev 2005 11 17-33
30. Gross C, Hansch D, Gastpar R, Multhoff G. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem 2003 384 267-279
31. Oroli N, Bai I. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP). Biomed Pharmacother 2005 59 561-570
32. Oroli N, Bai I. Cancer chemoprevention by propolis and its polyphenolic compounds in experimental animals. Singh VK, Govil JN, Arunachalam C Phytochemistry and pharmacology III. Recent progress in medicinal plants, Vol. 17. Houston, Texas, USA Studium Press, LLC 2007 55-113
33. Benkovi V, Horvat Kneevi A, Brozovic G, Kneevi F, iki D, Bevanda M, Bai I, Oroli N. Enhanced antitumor activity of irinotecan combinated with propolis and its polyphenolic compounds on Ehrlich ascites tumor in mice. Biomed Pharmacother 2007 61 292-297
34. Oroli N, Horvat-Kneevi A, Benkovi V, Bai I. Benefits of use of propolis and related flavonoids against the toxicity of chemotherapeutic agents. Scientific evidence of the use of propolis in ehtnomedicine. Oroli N, Bai I Ethnopharmacology review book. Kerala, India Research Signpost 2008 195-222
35. Shen R N., Lu L, Wu B, Shidnia H, Hornback N B., Broxmeyer H E. Effects of interleukin 2 treatment combined with local hyperthermia in mice inoculated with Lewis lung carcinoma cells. Cancer Res 1990 50 5027-5030
36. Roberts Jr N J. Temperature and host defense. Microbiol Rev 1979 43 241-259
37. Lindegaard J C., Radacic M, Khalil A A., Horsman M R., Overgaard J. Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature. Acta Oncol 1992 31 347-351
38. Mihich E. Historical overview of biologic response modifiers. Cancer Invest 2000 18 456-466
39. Ehrke M J. Immunomodulation in cancer therapeutics. Int Immunopharmacol 2003 3 1105-1119
40. Newman R A., Dogramatzis D, Benvenuto J A., Trevino M, Stephens L C., Wondergem J, Strebel R, Baba H, Bull J M. Effect of whole-body hyperthermia on pharmacokinetics and tissue distribution of doxorubicin. Int J Hyperthermia 1992 8 79-85
41. Momparler R L., Karon M, Siegel S E., Avila F. Effect of adriamycin on DNA, RNA and protein synthesis in cell-free systems and intact cells. Cancer Res 1976 36 2891-2895
42. Marmor J B. Interactions of hyperthermia and chemotherapy in animals. Cancer Res 1979 39 2269-2276
43. Fu Q G., Meng F D., Shen X D., Guo R X. Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection. World J Gastroenterol 2002 8 1019-1022
44. Comella P, Crucitta E, De Vita F, De Lucia L, Farris A, Del Gaizo F, Palmeri S, Lannelli A, Mancarella S, Tafuto S, Maiorino L, Buzzi F, De Cataldis G. Associated Institutions of the Southern Italy Cooperative Oncology Group. Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group. Ann Oncol 2002 13 866-873
45. Rothenberg M L., Oza A M., Bigelow R H., Berlin J D., Marshall J L., Ramanathan R K., Hart L L., Gupta S, Garay C A., Burger B G., Le Bail N, Haller D G. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 2003 21 2059-2069